Amerisource Bergen Specialty Group
GPTKB entity
Statements (46)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Amerisource_Bergen
|
| gptkbp:acquisition |
gptkb:Besse_Medical
World Wide Clinical Trials |
| gptkbp:ceo |
gptkb:Steven_H._Collis
|
| gptkbp:employees |
Over 1,000
|
| gptkbp:focus |
gptkb:healthcare_organization
gptkb:Company Inventory management Quality assurance Data analytics Hematology Patient safety Regulatory compliance Pharmacy services Patient support programs Biologics Logistics services Rare diseases Distribution services Clinical education Market access solutions Therapeutic areas Clinical trial services Infusion services Patient access solutions Reimbursement services |
| gptkbp:founded |
gptkb:2001
|
| gptkbp:headquarters |
gptkb:Conshohocken,_Pennsylvania
|
| https://www.w3.org/2000/01/rdf-schema#label |
Amerisource Bergen Specialty Group
|
| gptkbp:industry |
Pharmaceutical Distribution
|
| gptkbp:parent_company |
Amerisource Bergen Corporation
|
| gptkbp:partnership |
Healthcare systems
Various healthcare providers Pharmaceutical manufacturers |
| gptkbp:revenue |
Billions of dollars annually
|
| gptkbp:service_area |
gptkb:North_America
gptkb:United_States gptkb:Native_American_tribe |
| gptkbp:services |
Specialty pharmaceutical distribution
|
| gptkbp:subsidiary |
gptkb:Amerisource_Bergen_Drug_Corporation
gptkb:Besse_Medical Innomar Strategies World Wide Clinical Trials |
| gptkbp:website |
www.amerisourcebergen.com
|